HER2-positive Gastric Cancer Clinical Trial Pipeline: Insights into a Growing Landscape with 20+ Companies Advancing Novel Treatments| DelveInsight
The HER2-positive gastric cancer market is set for sustained growth, driven by rising global disease prevalence and expanded HER2 testing…